Increased generation of reactive oxygen species may underlie the pathophysi
ology of Friedreich ataxia (FRDA). The authors measured concentrations of 8
-hydroxy-2'-deoxyguanosine (8OH2'dG), a marker of oxidative DNA damage, in
urine and of dihydroxybenzoic acid (DHBA), a marker of hydroxyl radical att
ack, in plasma of 33 patients with FRDA. They found a 2.6-fold increase in
normalized urinary 8OH2'dG but no change in plasma DHBA as compared with co
ntrols. Oral treatment with 5 mg/kg/day of the antioxidant idebenone for 8
weeks significantly decreased urinary 8OH2'dG concentrations, indicating th
at 8OH2'dG may be useful in monitoring therapeutic interventions in patient
s with FRDA.